FCN1 and autoimmune disease: Moreover, Wb of serum obtained before and after IVIG therapy from patients with other autoimmune and systemic inflammatory diseases to which IVIG therapy has been successfully applied could provide support for the generally applicability of our FCN1 findings to other autoimmune diseases.